Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer

To investigate whether suppression of plasma estradiol and estrone sulfate levels by the aromatase inhibitors (AIs) anastrozole and letrozole is related to body mass index (BMI) in postmenopausal women with early estrogen receptor (ER) -positive breast cancer. Recent studies have reported that the A...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 30; no. 24; pp. 2977 - 2980
Main Authors Folkerd, Elizabeth J, Dixon, J Michael, Renshaw, Lorna, A'Hern, Roger P, Dowsett, Mitch
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Society of Clinical Oncology 20.08.2012
Subjects
Online AccessGet full text

Cover

Loading…